A single oral dose of flavan-3-ols enhances energy expenditure by sympathetic nerve stimulation in mice

Free Radical Biology and Medicine

Volumn 91, Issue , 2016, Pages 256-263

  Kamio, Naoya ^a   Suzuki, Takuma ^a   Watanabe, Yuto ^a   Suhara, Yoshitomo ^a   Osakabe, Naomi ^a  

^a SHIBAURA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

AMPK; Energy expenditure; Flavan 3 ols; Sympathetic nervesystem; Uncouplingprotein

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUTOXAMINE; FLAVAN 3 OL DERIVATIVE; FLAVANOL DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA; MESSENGER RNA; SR 52930; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 3; 3-(2-ETHYLPHENOXY)-1-(1,2,3,4-TETRAHYDRONAPHTH-1-YLAMINO)-2-PROPANOL OXALATE; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 3 ADRENERGIC RECEPTOR BLOCKING AGENT; FLAVAN-3-OL; FLAVONOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PPARGC1A PROTEIN, MOUSE; PROPANOLAMINE DERIVATIVE; UCP1 PROTEIN, MOUSE; UNCOUPLING PROTEIN 1;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG MECHANISM; ENERGY EXPENDITURE; ENZYME PHOSPHORYLATION; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYMPATHETIC NERVE; ADRENERGIC SYSTEM; ANIMAL; DRUG EFFECTS; ENERGY METABOLISM; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM;

ADRENERGIC BETA-2 RECEPTOR ANTAGONISTS; ADRENERGIC BETA-3 RECEPTOR ANTAGONISTS; ANIMALS; BUTOXAMINE; ENERGY METABOLISM; FLAVONOIDS; MALE; MICE, INBRED ICR; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR 1-ALPHA; PROPANOLAMINES; SYMPATHETIC NERVOUS SYSTEM; UNCOUPLING PROTEIN 1;

EID: 84954526691     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.12.030     Document Type: Article

References (59)

1. J.F. Hammerstone, S.A. Lazarus, A.E. Mitchell, R. Rucker, and H.H. Schmitz Identification of procyanidins in cocoa (Theobroma cacao) and chocolate using high-performance liquid chromatography/mass spectrometry J. Agric. Food Chem. 47 1999 490 496
2. T. Hatano, H. Miyatake, M. Natsume, N. Osakabe, T. Takizawa, H. Ito, and T. Yoshida Proanthocyanidin glycosides and related polyphenols from cacao liquor and their antioxidant effects Phytochemistry 59 2002 749 758
3. C. Sanbongi, N. Osakabe, M. Natsume, T. Takizawa, S. Gomi, and T. Osawa Antioxidative polyphenols isolated from Theobroma cacao J. Agric. Food Chem. 46 1998 454 457
4. A. Buitrago-Lopez, J. Sanderson, L. Johnson, S. Warnakula, A. Wood, E. Di Angelantonio, and O.H. Franco Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis Br. Med. J. (Clin. Res. Ed.) 343 2011 d4488
5. S.C. Larsson, J. Virtamo, and A. Wolk Chocolate consumption and risk of stroke: a prospective cohort of men and meta-analysis Neurology 79 2012 1223 1229
6. A.B. Petrone, J.M. Gaziano, and L. Djousse Chocolate consumption and risk of heart failure in the Physicians' Health Study Eur. J. Heart Fail. 16 2014 1372 1376
7. S. Desch, D. Kobler, J. Schmidt, M. Sonnabend, V. Adams, M. Sareban, I. Eitel, M. Bluher, G. Schuler, and H. Thiele Low vs. higher-dose dark chocolate and blood pressure in cardiovascular high-risk patients Am. J. Hypertens. 23 2010 694 700
8. D. Taubert, R. Berkels, R. Roesen, and W. Klaus Chocolate and blood pressure in elderly individuals with isolated systolic hypertension J. Am. Med. Assoc. 290 2003 1029 1030
9. M.B. Engler, M.M. Engler, C.Y. Chen, M.J. Malloy, A. Browne, E.Y. Chiu, H.K. Kwak, P. Milbury, S.M. Paul, J. Blumberg, and M.L. Mietus-Snyder Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults J. Am. Coll. Nutr. 23 2004 197 204
10. H. Schroeter, C. Heiss, J. Balzer, P. Kleinbongard, C.L. Keen, N.K. Hollenberg, H. Sies, C. Kwik-Uribe, H.H. Schmitz, and M. Kelm (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans Proc. Natl. Acad. Sci. U.S.A. 103 2006 1024 1029
11. S. Baba, M. Natsume, A. Yasuda, Y. Nakamura, T. Tamura, N. Osakabe, M. Kanegae, and K. Kondo LDL plasma and HDL cholesterol and oxidized LDL concentrations are altered in normo- and hypercholesterolemic humans after intake of different levels of cocoa powder J. Nutr. 137 2007 1436 1441
12. S. Baba, N. Osakabe, Y. Kato, M. Natsume, A. Yasuda, T. Kido, K. Fukuda, Y. Muto, and K. Kondo Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans Am. J. Clin. Nutr. 85 2007 709 717
13. J. Mursu, S. Voutilainen, T. Nurmi, T.H. Rissanen, J.K. Virtanen, J. Kaikkonen, K. Nyyssonen, and J.T. Salonen Dark chocolate consumption increases HDL cholesterol concentration and chocolate fatty acids may inhibit lipid peroxidation in healthy humans Free Radic. Biol. Med. 37 2004 1351 1359
14. D. Grassi, G. Desideri, S. Necozione, C. Lippi, R. Casale, G. Properzi, J.B. Blumberg, and C. Ferri Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate J. Nutr. 138 2008 1671 1676
15. D. Grassi, C. Lippi, S. Necozione, G. Desideri, and C. Ferri Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons Am. J. Clin. Nutr. 81 2005 611 614
16. S. Desch, D. Kobler, J. Schmidt, M. Sonnabend, V. Adams, M. Sareban, I. Eitel, M. Bluher, G. Schuler, and H. Thiele Low vs. higher-dose dark chocolate and blood pressure in cardiovascular high-risk patients Am. J. Hypertens. 23 2010 694 700
17. D. Grassi, G. Desideri, and C. Ferri Blood pressure and cardiovascular risk: what about cocoa and chocolate? Arch. Biochem. Biophys. 501 2010 112 115
18. K. Ried, T. Sullivan, P. Fakler, O.R. Frank, and N.P. Stocks Does chocolate reduce blood pressure? A meta-analysis BMC Med. 8 2010 39
19. O.A. Tokede, J.M. Gaziano, and L. Djousse Effects of cocoa products/dark chocolate on serum lipids: a meta-analysis Eur. J. Clin. Nutr. 65 2011 879 886
20. L. Hooper, C. Kay, A. Abdelhamid, P.A. Kroon, J.S. Cohn, E.B. Rimm, and A. Cassidy Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials Am. J. Clin. Nutr. 95 2012 740 751
21. K. Ried, T.R. Sullivan, P. Fakler, O.R. Frank, and N.P. Stocks Effect of cocoa on blood pressure Cd008893 Cochrane Database Syst. Rev. 8 2012
22. M.G. Shrime, S.R. Bauer, A.C. McDonald, N.H. Chowdhury, C.E. Coltart, and E.L. Ding Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies J. Nutr. 141 2011 1982 1988
23. B.A. Golomb, S. Koperski, and H.L. White Association between more frequent chocolate consumption and lower body mass index Arch. Intern. Med. 172 2012 519 521
24. M. Cuenca-Garcia, J.R. Ruiz, F.B. Ortega, and M.J. Castillo Association between chocolate consumption and fatness in European adolescents Nutrition 30 2014 236 239
25. N. Osakabe, J. Hoshi, N. Kudo, and M. Shibata The flavan-3-ol fraction of cocoa powder suppressed changes associated with early-stage metabolic syndrome in high-fat diet-fed rats Life Sci. 114 2014 51 56
26. N. Watanabe, K. Inagawa, M. Shibata, and N. Osakabe Flavan-3-ol fraction from cocoa powder promotes mitochondrial biogenesis in skeletal muscle in mice Lipids Health Dis. 13 2014 64
27. Y. Matsumura, Y. Nakagawa, K. Mikome, H. Yamamoto, and N. Osakabe Enhancement of energy expenditure following a single oral dose of flavan-3-ols associated with an increase in catecholamine secretion PLoS One 9 2014 e112180
28. P.A. Van Zwieten The role of adrenoceptors in circulatory and metabolic regulation Am. Heart J. 116 1988 1384 1392
29. A. Niijima Nervous regulation of metabolism Prog. Neurobiol. 33 1989 135 147
30. M. Natsume, N. Osakabe, M. Oyama, M. Sasaki, S. Baba, Y. Nakamura, T. Osawa, and J. Terao Structures of (-)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (-)-epicatechin: differences between human and rat Free Radic. Biol. Med. 34 2003 840 849
31. M.H. Tschop, J.R. Speakman, J.R. Arch, J. Auwerx, J.C. Bruning, L. Chan, R.H. Eckel, R.V. Farese Jr., J.E. Galgani, C. Hambly, M.A. Herman, T.L. Horvath, B.B. Kahn, S.C. Kozma, E. Maratos-Flier, T.D. Muller, H. Munzberg, P.T. Pfluger, L. Plum, M.L. Reitman, K. Rahmouni, G.I. Shulman, G. Thomas, C.R. Kahn, and E. Ravussin A guide to analysis of mouse energy metabolism Nat. Methods 9 2012 57 63
32. J. Axelrod, and R. Weinshilboum Catecholamines N. Engl. J. Med. 287 1972 237 242
33. M. Kjaer, N.H. Secher, and H. Galbo Physical stress and catecholamine release Bailliere's Clin. Endocrinol. Metab. 1 1987 279 298
34. N. Tentolouris, S. Liatis, and N. Katsilambros Sympathetic system activity in obesity and metabolic syndrome Ann. N. Y. Acad. Sci. 1083 2006 129 152
35. K.P. Davy, and J.S. Orr Sympathetic nervous system behavior in human obesity Neurosci. Biobehav. Rev. 33 2009 116 124
36. D. Steinberg Hormonal control of lipolysis in adipose tissue Adv. Exp. Med. Biol. 26 1972 77 88
37. H. Meisner, and J.R. Carter Jr. Regulation of lipolysis in adipose tissue Horizons Biochem. Biophys. 4 1977 91 129
38. R. Levine, and D.E. Haft Carbohydrate homeostasis N. Engl. J. Med. 283 1970 237 246
39. M.G. Clark, G.S. Patten, O.H. Filsell, and S. Rattigan Co-ordinated regulation of muscle glycolysis and hepatic glucose output in exercise by catecholamines acting via alpha-receptors FEBS Lett. 158 1983 1 6
40. M. Tadaishi, S. Miura, Y. Kai, E. Kawasaki, K. Koshinaka, K. Kawanaka, J. Nagata, Y. Oishi, and O. Ezaki Effect of exercise intensity and AICAR on isoform-specific expressions of murine skeletal muscle PGC-1alpha mRNA: a role of beta(2)-adrenergic receptor activation Am. J. Physiol. Endocrinol. Metab. 300 2011 E341 E349
41. F.T. Verstappen, and M.A. van Baak Exercise capacity, energy metabolism, and beta-adrenoceptor blockade. Comparison between a beta 1-selective and a non-selective beta blocker Eur. J. Appl. Physiol. Occup. Physiol. 56 1987 712 718
42. H.G. Predel, W. Mainka, W. Schillings, H. Knigge, J. Montiel, J. Fallois, R. Agrawal, T. Schramm, C. Graf, B.M. Giannetti, B. Bjarnason-Wehrens, U. Prinz, and R.E. Rost Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension J. Hum. Hypertens. 15 2001 715 721
43. G. Haeusler Pharmacology of beta-blockers: classical aspects and recent developments J. Cardiovasc. Pharmacol. 16 Suppl 5 1990 S1 S9
44. M.A. Emrick, M. Sadilek, K. Konoki, and W.A. Catterall Beta-adrenergic-regulated phosphorylation of the skeletal muscle Ca(V)1.1 channel in the fight-or-flight response Proc. Natl. Acad. Sci. U.S.A. 107 2010 18712 18717
45. O.R. Joassard, A.C. Durieux, and D.G. Freyssenet beta2-Adrenergic agonists and the treatment of skeletal muscle wasting disorders Int. J. Biochem. Cell. Biol. 45 2013 2309 2321
46. R. Rudolf, M.M. Khan, D. Lustrino, S. Labeit, I.C. Kettelhut, and L.C. Navegantes Alterations of cAMP-dependent signaling in dystrophic skeletal muscle Front. Physiol. 4 2013 290
47. Y. Liu, and M.F. Schneider Opposing HDAC4 nuclear fluxes due to phosphorylation by beta-adrenergic activated protein kinase A or by activity or Epac activated CaMKII in skeletal muscle fibres J. Physiol. 591 2013 3605 3623
48. A.M. Sanchez, R.B. Candau, A. Csibi, A.F. Pagano, A. Raibon, and H. Bernardi Am. J. Physiol. Cell. Physiol. 303 2012 C475 C485
49. C.T. Putman, M. Kiricsi, J. Pearcey, I.M. MacLean, J.A. Bamford, G.K. Murdoch, W.T. Dixon, and D. Pette AMPK activation increases uncoupling protein-3 expression and mitochondrial enzyme activities in rat muscle without fibre type transitions J. Physiol. 551 2003 169 178
50. J. Hoeks, M.A. van Baak, M.K. Hesselink, G.B. Hul, H. Vidal, W.H. Saris, and P. Schrauwen Effect of beta1- and beta2-adrenergic stimulation on energy expenditure, substrate oxidation, and UCP3 expression in humans Am. J. Physiol. Endocrinol. Metab. 285 2003 E775 E782
51. B. Cannon, and J. Nedergaard Brown adipose tissue: function and physiological significance Physiol. Rev. 84 2004 277 359
52. R.A. Mund, and W.H. Frishman Brown adipose tissue thermogenesis: beta3-adrenoreceptors as a potential target for the treatment of obesity in humans Cardiol. Rev. 21 2013 265 269
53. B.B. Lowell, and B.M. Spiegelman Towards a molecular understanding of adaptive thermogenesis Nature 404 2000 652 660
54. S. Baba, N. Osakabe, A. Yasuda, M. Natsume, T. Takizawa, T. Nakamura, and J. Terao Bioavailability of (-)-epicatechin upon intake of chocolate and cocoa in human volunteers Free Radic. Res. 33 2000 635 641
55. M.N. Clifford, J.J. van der Hooft, and A. Crozier Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols Am. J. Clin. Nutr. 98 2013 1619s 1630s
56. S. Baba, N. Osakabe, M. Natsume, and J. Terao Absorption and urinary excretion of procyanidin B2 [epicatechin-(4beta-8)-epicatechin] in rats Free Radic. Biol. Med. 33 2002 142 148
57. A. Serra, A. Macia, M.P. Romero, J. Valls, C. Blade, L. Arola, and M.J. Motilva Bioavailability of procyanidin dimers and trimers and matrix food effects in in vitro and in vivo models Br. J. Nutr. 103 2010 944 952
58. G.P. Ahern Transient receptor potential channels and energy homeostasis Trends Endocrinol. Metab. 24 2013 554 560
59. M. Kurogi, Y. Kawai, K. Nagatomo, M. Tateyama, Y. Kubo, and O. Saitoh Auto-oxidation products of epigallocatechin gallate activate TRPA1 and TRPV1 in sensory neurons Chem. Senses 40 2015 27 46